Clinical trial
Novel Dose Escalation to Predict Treatment With Hydroxyurea
NCT02042222 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Dose Escalation to Predict Treatment With Hydroxyurea
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- July 31, 2020
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease